10x Genomics (TXG)
10x Genomics on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as laboratory analytical instruments.
15.4M
Short interest
settlement 2026-09-30
4.5
Days to cover
-2.6 days vs prior
45.8%
Short share of volume
2026-10-09
104,581
Fails to deliver
settlement 2026-09-11
Thu 5 Nov
Next earnings
estimated date
-$12.2M
Insider flow, 90 days
0 buys, 28 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in TXG is 15,371,598 shares, down 790,257 shares over the last month. Over the last 48 readings it ranged from 6,171,260 shares (13 December 2024) to 22,153,766 shares (15 May 2026). At the reported average volume of 3.4M shares a day that is 4.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/txg" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 15,371,598 | -7.9% | 3,393,658 | 4.53 |
| 2026-09-15 | 16,692,300 | +3.3% | 2,354,383 | 7.09 |
| 2026-08-31 | 16,161,855 | +1.5% | 2,931,813 | 5.51 |
| 2026-08-14 | 15,927,548 | +1.9% | 3,483,708 | 4.57 |
| 2026-07-31 | 15,625,594 | -3.9% | 2,697,443 | 5.79 |
| 2026-07-15 | 16,252,519 | -0.5% | 3,043,005 | 5.34 |
| 2026-06-30 | 16,339,596 | -26.1% | 3,881,703 | 4.21 |
| 2026-06-15 | 22,103,160 | +34.0% | 3,264,017 | 6.77 |
| 2026-05-29 | 16,492,737 | -25.6% | 3,023,390 | 5.46 |
| 2026-05-15 | 22,153,766 | +36.4% | 2,792,093 | 7.93 |
| 2026-04-30 | 16,248,294 | -1.4% | 2,656,525 | 6.12 |
| 2026-04-15 | 16,474,248 | +2.8% | 2,307,371 | 7.14 |
| 2026-03-31 | 16,020,777 | +1.3% | 2,448,182 | 6.54 |
| 2026-03-13 | 15,810,579 | -3.6% | 1,950,555 | 8.11 |
| 2026-02-27 | 16,396,134 | -11.4% | 2,556,365 | 6.41 |
| 2026-02-13 | 18,515,015 | +13.5% | 3,079,099 | 6.01 |
| 2026-01-30 | 16,318,045 | -0.2% | 2,438,368 | 6.69 |
| 2026-01-15 | 16,344,883 | +7.8% | 2,873,340 | 5.69 |
| 2025-12-31 | 15,158,374 | -1.7% | 1,712,985 | 8.85 |
| 2025-12-15 | 15,420,723 | +4.2% | 2,149,325 | 7.17 |
| 2025-11-28 | 14,803,796 | -4.5% | 3,210,420 | 4.61 |
| 2025-11-14 | 15,501,651 | +3.2% | 3,696,153 | 4.19 |
| 2025-10-31 | 15,016,478 | +19.7% | 2,694,671 | 5.57 |
| 2025-10-15 | 12,546,318 | -0.2% | 2,417,897 | 5.19 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of TXG volume is 45.8%, down 1.0 points over the last five sessions. Over the last 30 readings it ranged from 24.4% (8 October 2026) to 77.1% (9 September 2026). The latest reading is 8.5 points below the 30-session average of 54.3%, on 1.8M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 819K | 1.8M | 45.8% | 375 |
| 2026-10-08 | 721K | 3.0M | 24.4% | 1,843 |
| 2026-10-07 | 1.2M | 4.5M | 27.1% | 26,236 |
| 2026-10-06 | 1.9M | 4.2M | 46.1% | 173,758 |
| 2026-10-05 | 810K | 1.3M | 62.8% | 135 |
| 2026-10-02 | 798K | 1.7M | 46.8% | 325 |
| 2026-10-01 | 588K | 1.5M | 38.6% | 469 |
| 2026-09-30 | 915K | 1.7M | 54.9% | 3,473 |
| 2026-09-29 | 944K | 1.9M | 50.3% | 1,237 |
| 2026-09-28 | 1.1M | 1.6M | 71.4% | 1,100 |
| 2026-09-25 | 780K | 1.5M | 51.0% | 781 |
| 2026-09-24 | 911K | 2.1M | 43.6% | 3,632 |
| 2026-09-23 | 752K | 1.9M | 40.6% | 1,094 |
| 2026-09-22 | 879K | 1.9M | 46.0% | 6,675 |
| 2026-09-21 | 616K | 980K | 62.8% | 9,855 |
| 2026-09-18 | 431K | 827K | 52.1% | 480 |
| 2026-09-17 | 656K | 1.6M | 42.3% | 29,929 |
| 2026-09-16 | 826K | 1.9M | 43.4% | 1,979 |
| 2026-09-15 | 1.0M | 1.5M | 68.1% | 10,103 |
| 2026-09-14 | 1.0M | 1.7M | 58.6% | 8,611 |
| 2026-09-11 | 554K | 839K | 66.0% | 594 |
| 2026-09-10 | 677K | 932K | 72.6% | 24 |
| 2026-09-09 | 957K | 1.2M | 77.1% | 139,184 |
| 2026-09-08 | 955K | 1.3M | 70.9% | 132 |
| 2026-09-04 | 507K | 658K | 77.0% | 617 |
| 2026-09-03 | 637K | 985K | 64.7% | 2,151 |
| 2026-09-02 | 345K | 693K | 49.9% | 129 |
| 2026-09-01 | 572K | 829K | 69.0% | 334 |
| 2026-08-31 | 578K | 1.1M | 54.1% | 12,870 |
| 2026-08-28 | 564K | 1.1M | 50.9% | 4,952 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 11 September 2026, the fails-to-deliver balance in TXG is 104,581 shares, up 104,580 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (22 April 2026) to 185,128 shares (13 August 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-11 | 104,581 | $66.38 | $6.9M |
| 2026-09-04 | 1 | $63.22 | $63 |
| 2026-08-31 | 80 | $61.54 | $5K |
| 2026-08-24 | 6,430 | $65.12 | $419K |
| 2026-08-21 | 19,127 | $63.87 | $1.2M |
| 2026-08-19 | 228 | $55.63 | $13K |
| 2026-08-13 | 185,128 | $57.75 | $10.7M |
| 2026-08-12 | 7,033 | $58.48 | $411K |
| 2026-08-11 | 1,575 | $58.57 | $92K |
| 2026-08-06 | 4,296 | $47.46 | $204K |
| 2026-07-29 | 4,276 | $47.05 | $201K |
| 2026-07-27 | 5,569 | $46.27 | $258K |
| 2026-07-21 | 25 | $43.22 | $1K |
| 2026-07-17 | 23,533 | $44.48 | $1.0M |
| 2026-07-16 | 323 | $45.75 | $15K |
| 2026-07-01 | 37 | $38.34 | $1K |
| 2026-06-30 | 29,751 | $37.15 | $1.1M |
| 2026-06-24 | 72 | $31.87 | $2K |
| 2026-06-22 | 2,282 | $34.76 | $79K |
| 2026-06-12 | 7,078 | $29.05 | $206K |
| 2026-06-08 | 67 | $31.04 | $2K |
| 2026-06-02 | 14,520 | $29.59 | $430K |
| 2026-06-01 | 510 | $28.31 | $14K |
| 2026-05-26 | 92 | $23.68 | $2K |
| 2026-05-15 | 29,435 | $21.52 | $633K |
| 2026-05-04 | 8,996 | $22.43 | $202K |
| 2026-04-27 | 35,762 | $22.08 | $790K |
| 2026-04-24 | 7,350 | $21.42 | $157K |
| 2026-04-22 | 1 | $22.97 | $23 |
| 2026-04-20 | 17,136 | $26.08 | $447K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at TXG reported 28 open-market sells worth $12.2M in the last 90 days and no open-market buys. Latest filing: SULIMAN SHEHNAAZ (Director) on 2026-09-22.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-22 | SULIMAN SHEHNAAZ | Director | Sell | 1K | $82.28 | $101K | 24K |
| 2026-09-22 | SULIMAN SHEHNAAZ | Director | Sell | 2K | $81.67 | $185K | 25K |
| 2026-09-22 | SULIMAN SHEHNAAZ | Director | Sell | 1K | $80.82 | $107K | 27K |
| 2026-09-22 | SULIMAN SHEHNAAZ | Director | Sell | 614 | $79.51 | $49K | 29K |
| 2026-09-22 | SULIMAN SHEHNAAZ | Director | Sell | 292 | $78.20 | $23K | 29K |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Sell | 3K | $82.36 | $231K | 1.1M |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Sell | 10K | $81.83 | $810K | 1.1M |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Sell | 9K | $80.90 | $752K | 1.1M |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Sell | 2K | $79.62 | $159K | 1.1M |
| 2026-09-22 | Saxonov Serge | Chief Executive Officer | Sell | 1K | $78.23 | $78K | 1.1M |
| 2026-09-09 | Taich Adam | Chief Financial Officer | Sell | 14K | $65.26 | $898K | 316K |
| 2026-09-09 | Taich Adam | Chief Financial Officer | Sell | 31K | $64.31 | $2.0M | 330K |
| 2026-09-09 | Taich Adam | Chief Financial Officer | Sell | 1K | $63.68 | $77K | 362K |
| 2026-09-03 | STUELPNAGEL JOHN R | Director | Sell | 6K | $62.61 | $387K | 328K |
| 2026-09-03 | STUELPNAGEL JOHN R | Director | Sell | 7K | $62.11 | $423K | 335K |
| 2026-09-03 | STUELPNAGEL JOHN R | Director | Sell | 7K | $60.66 | $425K | 341K |
| 2026-09-01 | Saxonov Serge | Chief Executive Officer | Gift | 100 | $0.00 | $0 | 1.1M |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | Sell | 492 | $64.75 | $32K | 1.1M |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | Sell | 6K | $63.98 | $415K | 1.1M |
| 2026-08-26 | Saxonov Serge | Chief Executive Officer | Sell | 4K | $63.02 | $221K | 1.1M |
| 2026-08-24 | Saxonov Serge | Chief Executive Officer | Sell | 19K | $63.02 | $1.2M | 1.1M |
| 2026-08-24 | Taich Adam | Chief Financial Officer | Sell | 17K | $63.02 | $1.1M | 363K |
| 2026-08-24 | Hindson Benjamin J. | See Remarks | Sell | 14K | $63.02 | $871K | 488K |
| 2026-08-24 | SULIMAN SHEHNAAZ | Director | Sell | 2K | $63.97 | $105K | 30K |
| 2026-08-24 | SULIMAN SHEHNAAZ | Director | Sell | 561 | $62.73 | $35K | 31K |
| 2026-08-20 | Saxonov Serge | Chief Executive Officer | Gift | 4K | $0.00 | $0 | 1.1M |
| 2026-08-14 | Teichmann Sarah A. | Director | Sell | 2K | $57.15 | $130K | 28K |
| 2026-08-13 | Teichmann Sarah A. | Director | Sell | 5K | $57.29 | $302K | 30K |
| 2026-08-11 | STUELPNAGEL JOHN R | Director | Sell | 3K | $58.73 | $176K | 348K |
| 2026-08-11 | STUELPNAGEL JOHN R | Director | Sell | 17K | $57.58 | $979K | 351K |
| 2026-06-22 | Saxonov Serge | Chief Executive Officer | Sell | 2K | $36.16 | $60K | 1.1M |
| 2026-06-22 | Saxonov Serge | Chief Executive Officer | Sell | 10K | $35.32 | $347K | 1.1M |
| 2026-06-22 | Saxonov Serge | Chief Executive Officer | Sell | 10K | $34.28 | $343K | 1.1M |
| 2026-06-22 | Saxonov Serge | Chief Executive Officer | Sell | 9K | $33.29 | $284K | 1.1M |
| 2026-06-16 | SULIMAN SHEHNAAZ | Director | Sell | 364 | $33.27 | $12K | 32K |
| 2026-06-16 | SULIMAN SHEHNAAZ | Director | Sell | 5K | $32.59 | $175K | 32K |
| 2026-06-04 | Teichmann Sarah A. | Director | Grant | 9K | $0.00 | $0 | 36K |
| 2026-06-04 | SULIMAN SHEHNAAZ | Director | Grant | 9K | $0.00 | $0 | 37K |
| 2026-06-04 | STUELPNAGEL JOHN R | Director | Grant | 9K | $0.00 | $0 | 368K |
| 2026-06-04 | Popovits Kimberly J | Director | Grant | 9K | $0.00 | $0 | 37K |
| 2026-06-04 | MATEO ALAN | Director | Grant | 9K | $0.00 | $0 | 86K |
| 2026-06-04 | Kosaraju Sridhar | Director | Grant | 9K | $0.00 | $0 | 65K |
| 2026-05-26 | Saxonov Serge | Chief Executive Officer | Sell | 11K | $24.71 | $265K | 1.1M |
| 2026-05-22 | Saxonov Serge | Chief Executive Officer | Sell | 18K | $24.44 | $444K | 1.1M |
| 2026-05-22 | Hindson Benjamin J. | See Remarks | Sell | 12K | $24.44 | $283K | 502K |
| 2026-05-22 | Taich Adam | Chief Financial Officer | Sell | 15K | $24.44 | $369K | 380K |
| 2026-04-14 | Saxonov Serge | Chief Executive Officer | Sell | 5K | $24.56 | $123K | 1.2M |
| 2026-03-24 | Saxonov Serge | Chief Executive Officer | Sell | 5K | $19.52 | $98K | 1.2M |
| 2026-03-23 | Saxonov Serge | Chief Executive Officer | Sell | 10K | $19.13 | $191K | 1.2M |
| 2026-03-03 | Saxonov Serge | Chief Executive Officer | Gift | 3K | $0.00 | $0 | 1.2M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON19 Form 144 notices on file for TXG worth $12.1M at the prices reported; 8 in the last 90 days worth $8.9M. Latest: ADAM TAICH filed on 2026-09-09 to sell 46,388 shares ($3.0M) from 2026-09-09.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-09 | ADAM TAICHOfficer | 46K | $3.0M | 0.039% | 2026-09-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-03 | STUELPNAGEL JOHN RDirector | 20K | $1.2M | 0.017% | 2026-09-03 | Wells Fargo Clearing Services |
| 2026-08-24 | Taich AdamOfficer | 17K | $1.1M | 0.014% | 2026-08-24 | Morgan Stanley Smith Barney LLC |
| 2026-08-24 | Saxonov SergeOfficer, Director | 18K | $1.2M | 0.015% | 2026-08-24 | Morgan Stanley Smith Barney LLC |
| 2026-08-24 | Hindson Benjamin J.Officer, Director | 13K | $871K | 0.011% | 2026-08-24 | Morgan Stanley Smith Barney LLC |
| 2026-08-14 | SARAH A POLONIUS-TEICHMANNDirector | 2K | $130K | 0.002% | 2026-08-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-13 | SARAH A POLONIUS-TEICHMANNDirector | 5K | $302K | 0.004% | 2026-08-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-11 | STUELPNAGEL JOHN RDirector | 20K | $1.2M | 0.017% | 2026-08-11 | Wells Fargo Clearing Services |
| 2026-05-22 | Taich AdamOfficer | 12K | $291K | 0.010% | 2026-05-22 | Morgan Stanley Smith Barney LLC Executive Services |
| 2026-05-22 | Saxonov SergeOfficer, Director | 18K | $443K | 0.015% | 2026-05-22 | Morgan Stanley Smith Barney LLC, Executive Services |
| 2026-05-22 | Hindson Benjamin J.Officer, Director | 9K | $233K | 0.008% | 2026-05-22 | Morgan Stanley Smith Barney LLC Executive Services |
| 2026-03-02 | Serge SaxonovDirector, CEO | 41K | $911K | 0.035% | 2026-03-02 | JP Morgan Securities LLC |
| 2026-02-25 | SARAH A POLONIUS-TEICHMANNDirector | 8K | $147K | 0.006% | 2026-02-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-23 | Taich AdamOfficer | 9K | $176K | 0.008% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Services |
| 2026-02-23 | Saxonov SergeOfficer, Director | 10K | $194K | 0.009% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Services |
| 2026-02-23 | Hindson Benjamin J.Officer, Director | 8K | $159K | 0.007% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Services |
| 2025-11-24 | Taich AdamOfficer | 11K | $207K | 0.010% | 2025-11-24 | Morgan Stanley Smith Barney LLC Executive Services |
| 2025-11-24 | Saxonov SergeOfficer, Director | 13K | $240K | 0.011% | 2025-11-24 | Morgan Stanley Smith Barney LLC Executive Services |
| 2025-11-24 | Hindson Benjamin J.Officer, Director | 7K | $136K | 0.006% | 2025-11-24 | Morgan Stanley Smith Barney LLC Executive Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON7 holders report 5% or more of TXG in their latest filing, all on Schedule 13G (passive). The largest reported stake is FMR LLC at 15.6% of the class (18,543,562 shares), filed 2026-03-06 for an event on 2026-02-27.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-07 | 13G/Ano. 4 | Catherine D. Woodparent holding company, individual | 6.3M | 5.2% | 2026-09-30 |
| 2026-10-07 | 13G/Ano. 4 | ARK Investment Management LLCinvestment adviser | 6.3M | 5.2% | 2026-09-30 |
| 2026-09-08 | 13G | T. Rowe Price Associates, Inc.investment adviser | 14.0M | 11.7% | 2026-08-31 |
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 6.2M | 5.2% | 2026-03-31 |
| 2026-04-28 | 13G | Vanguard Portfolio Managementinvestment adviser | 7.0M | 5.9% | 2026-03-31 |
| 2026-03-25 | 13G/Ano. 7 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-03-06 | 13G/Ano. 14 | FMR LLCparent holding company | 18.5M | 15.6% | 2026-02-27 |
| 2026-03-06 | 13G/Ano. 14 | Abigail P. Johnsonindividual | 18.5M | 15.6% | 2026-02-27 |
| 2025-11-13 | 13G/Ano. 1 | Amova Asset Management Americas, Inc.investment adviser | 5.4M | 4.7% | 2025-09-30 |
| 2025-10-27 | 13G/Ano. 1 | Sumitomo Mitsui Trust Group, Inc.parent holding company, non-US institution | 5.4M | 4.7% | 2025-09-30 |
| 2025-10-27 | 13G/Ano. 1 | Amova Asset Management Co., Ltd.investment adviser, parent holding company, non-US institution | 5.4M | 4.7% | 2025-09-30 |
13F holders
Tracked managers holding TXG at their latest 13F. JSON10 of the 30 tracked managers held TXG at their latest 13F, $701.4M in total at quarter-end prices. ARK Investment Management is the largest at $383.5M (2.5% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 6 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| ARK Investment Management | 2026-06-30 | 10.0M | $383.5M | 2.49% | -1.7M |
| Citadel Advisors | 2026-06-30 | 2.8M | $106.6M | 0.01% | +2.0M |
| AQR Capital Management | 2026-06-30 | 2.0M | $74.7M | 0.03% | -512K |
| Point72 Asset Management | 2026-06-30 | 1.9M | $71.0M | 0.08% | new |
| Renaissance Technologies | 2026-06-30 | 802K | $30.8M | 0.04% | -207K |
| Duquesne Family Office | 2026-06-30 | 403K | $15.5M | 0.30% | new |
| D. E. Shaw & Co. | 2026-06-30 | 233K | $8.9M | 0.00% | +165K |
| Two Sigma Investments | 2026-06-30 | 142K | $5.4M | 0.00% | -261K |
| Millennium Management | 2026-06-30 | 117K | $4.5M | 0.00% | -2.0M |
| Bridgewater Associates | 2026-06-30 | 13K | $513K | 0.00% | -22K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) 10x Genomics reported revenue of $151.0M, down 12.6% from the same quarter a year earlier, and net loss of $17.9M (-0.14 diluted EPS). In FY 2025 it generated $136.1M of operating cash flow.
- Equity
- $825.5M
- Total assets
- $1.03B
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $151.0M | -$17.9M | -11.9% | -0.14 |
| Q1 FY 2026 | 2026-03-31 | $150.8M | -$13.5M | -8.9% | -0.10 |
| Q4 FY 2025derived | 2025-12-31 | $166.0M | -$16.3M | -9.8% | n/a |
| Q3 FY 2025 | 2025-09-30 | $149.0M | -$27.5M | -18.4% | -0.22 |
| Q2 FY 2025 | 2025-06-30 | $172.9M | $34.5M | 20.0% | 0.28 |
| Q1 FY 2025 | 2025-03-31 | $154.9M | -$34.4M | -22.2% | -0.28 |
| Q4 FY 2024derived | 2024-12-31 | $165.0M | -$49.0M | -29.7% | n/a |
| Q3 FY 2024 | 2024-09-30 | $151.7M | -$35.8M | -23.6% | -0.30 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $642.8M | -$43.5M | $136.1M | $5.9M | n/a | n/a |
| FY 2024 | 2024-12-31 | $610.8M | -$182.6M | $6.7M | $12.4M | n/a | n/a |
| FY 2023 | 2023-12-31 | $618.7M | -$255.1M | -$15.2M | $48.6M | n/a | n/a |
| FY 2022 | 2022-12-31 | $516.4M | -$166.0M | -$33.6M | $131.7M | n/a | n/a |
| FY 2021 | 2021-12-31 | $490.5M | -$58.2M | -$21.4M | $101.3M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30.
What this page is
10x Genomics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows 10x Genomics (TXG), SEC CIK 1770787, listed on Nasdaq, classified by the SEC as laboratory analytical instruments. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-11.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-09.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-07.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-22.JSON and CSV
- Company record
- EDGAR filing index for CIK 1770787Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as laboratory analytical instruments
Other company pages
Datasets
Frequently Asked Questions
How much of TXG is sold short?
What is TXG's daily short volume?
Does TXG have fails to deliver?
Are TXG insiders buying or selling?
Have TXG insiders filed to sell?
Who owns 5% or more of TXG?
What did TXG report last quarter?
Which tracked 13F managers own TXG?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.